UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 5, 2015

 

THORATEC CORPORATION

(Exact name of registrant as specified in its charter)

 

California

 

000-49798

 

94-2340464

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

6035 Stoneridge Drive

Pleasanton, California  94588

(Address of principal executive offices including zip code)

 

(925) 847-8600

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07.             Submission of Matters to a Vote of Security Holders.

 

At the Thoratec Corporation (the “Company”) Annual Meeting of Shareholders held on May 5, 2015, the shareholders of the Company voted on the following five proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on March 24, 2015.

 

Proposal No. 1: To elect eight directors to serve for the ensuing year or until their successors are elected and qualified:

 

 

 

Number of Votes

 

 

 

For

 

Withheld

 

Non Votes

 

Neil F. Dimick

 

37,125,949

 

4,810,916

 

5,515,270

 

D. Keith Grossman

 

41,778,760

 

158,105

 

5,515,270

 

J. Daniel Cole

 

41,577,779

 

359,086

 

5,515,270

 

Steven H. Collis

 

41,381,305

 

555,560

 

5,515,270

 

William A. Hawkins, III

 

41,584,915

 

351,950

 

5,515,270

 

Paul A. LaViolette

 

41,609,876

 

326,989

 

5,515,270

 

Martha H. Marsh

 

41,781,619

 

155,246

 

5,515,270

 

Todd C. Schermerhorn

 

41,779,257

 

157,608

 

5,515,270

 

 

Proposal No. 2:  To approve an amendment and restatement of the Thoratec Corporation Amended and Restated 2006 Incentive Stock Plan increasing the number of shares of common stock reserved for issuance thereunder and revising certain provisions thereunder:

 

 

 

Number of Votes

 

For

 

38,958,808

 

Against

 

2,956,136

 

Abstain

 

21,921

 

Non Votes

 

5,515,270

 

 

Proposal No. 3: To approve an amendment and restatement of the Thoratec Corporation 2002 Employee Stock Purchase Plan increasing the number of shares of common stock reserved for issuance thereunder and revising certain provisions thereunder:

 

 

 

Number of Votes

 

For

 

41,038,215

 

Against

 

879,236

 

Abstain

 

19,414

 

Non Votes

 

5,515,270

 

 

Proposal No. 4:  To conduct an advisory vote on the compensation of the Company’s named executive officers:

 

 

 

Number of Votes

 

For

 

40,134,552

 

Against

 

1,723,282

 

Abstain

 

79,031

 

Non Votes

 

5,515,270

 

 

Proposal No. 5:  To ratify the appointment of Deloitte & Touche LLP as independent auditors of the Company for its fiscal year ending January 2, 2016:

 

 

 

Number of Votes

 

For

 

47,337,635

 

Against

 

105,569

 

Abstain

 

8,931

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated as of May 8, 2015

 

 

 

 

THORATEC CORPORATION

 

 

 

 

By:

/s/ D. Keith Grossman

 

 

 

 

 

D. Keith Grossman

 

 

President and Chief Executive Officer

 

3